Stoke Therapeutics (STOK) Cash & Equivalents (QoQ) (2018 - 2026)
Powered by 
Analysis
Stoke Therapeutics (STOK) Cash & Equivalents (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Stoke Therapeutics | 1.96 Bn | 1.66 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.33% |
| Mar 31, 2026 | 84.82% |
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | -17.82% |
| Jun 30, 2025 | -63.08% |
| Mar 31, 2025 | 114.73% |
| Dec 31, 2024 | -14.69% |
| Sep 30, 2024 | -22.46% |
| Jun 30, 2024 | 8.34% |
| Mar 31, 2024 | -6.72% |
| Dec 31, 2023 | 0.77% |
| Sep 30, 2023 | -1.08% |
| Jun 30, 2023 | 0.90% |
| Mar 31, 2023 | 67.62% |
| Dec 31, 2022 | 0.14% |
| Sep 30, 2022 | 67.36% |
| Jun 30, 2022 | -19.45% |
| Mar 31, 2022 | -41.95% |
| Dec 31, 2021 | -2.78% |
| Sep 30, 2021 | -11.85% |